Press

Cybin

Cybin to Commence Trading on the NYSE American on August 5

Quick Take: Cybin will begin trading on the NYSE today under the ticker “CYBN” Cybin Inc. (NEO:CYBN), a biotechnology company focused on progressing psychedelic therapeutics, today announced that its common shares will open for trading on the NYSE American LLC stock exchange (“NYSE American”)on August 5, 2021, under the symbol “CYBN”.   In addition to listing […]

Awakn life sciences

Awakn Life Sciences Announces Its Second Location in the UK for “Awakn Clinics London,” Providing Treatment to the Largest City in the UK

Quick Take: Awakn has announced its plans to open a psychedelic treatment clinic in the city of London. Awakn Life Sciences Corp. (NEO: AWKN), a biotechnology company with clinical operations developing and delivering psychedelic medicines to better treat Addiction, today announced the signing of its 10-year lease to open Awakn Clinics London, a psychedelic-focused therapy […]

Tryp Therapeutics

Tryp Therapeutics to Present at Canaccord Genuity Annual Growth Conference

Quick Take: Tryp Therapeutics is slated to present at the Canaccord Genuity Annual Growth Conference. Tryp Therapeutics (CSE: TRYP), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs through accelerated regulatory pathways, announced today that it will present at the Canaccord Genuity Virtual Growth Conference. The conference will be held virtually […]

MindMed

MindMed Joins Digital Medicine Society to Improve Health Outcomes and Equity Using Technology

Quick Take: MindMed has joined Digital Medicine Society, an organization dedicated to improving medical practices and outcomes through technology. MindMed (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ), a leading biotech company developing psychedelic-inspired therapies, announced today that it will participate in and financially support the Digital Medicine Society’s (DiMe) Digital Health Measurement Collaborative Community (DATAcc), an effort […]